Christopher Kennedy's unexpected diagnosis of idiopathic pulmonary fibrosis transformed his life. As he faced deteriorating health, a double-lung transplant became his beacon of hope, leading to a remarkable recovery and a renewed appreciation for life.
As gene therapy for Duchenne muscular dystrophy faces scrutiny after tragic deaths, families like the Revells navigate the uncertain waters of hope and risk, questioning the future of their loved ones.
Medical staff in Gaza are collapsing from hunger while trying to care for malnourished patients. With no food available, they face impossible choices between work and survival.
A child in the Midlands has tragically died from a brain-eating amoeba infection, raising alarm about water safety. Experts stress the rarity of such infections but urge caution in freshwater activities.
Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy is on hold due to safety issues. An FDA official warns the path to market approval is fraught with challenges, especially after patient deaths linked to liver injuries.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
Sarepta Therapeutics is under fire as another patient succumbs to acute liver failure linked to its gene therapy trial for muscular dystrophy, adding to the recent deaths of two teenage boys.
Philadelphia health officials have detected West Nile virus in mosquitoes near Pennypack Park, urging residents to take precautions against the disease. Symptoms to watch for include neurological issues, and medical providers have been alerted to test patients as the health department expects more positive cases.
A person in northern Arizona has died from bubonic plague, highlighting the rarity of this disease today. Local health officials confirm the patient was treated but did not survive. Investigations are ongoing.
A new review claims antidepressants don’t cause significant withdrawal effects, but new research suggests otherwise. Long-term users may face severe and debilitating symptoms after stopping. Find out the shocking reality behind antidepressant withdrawal.
